|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| C12N 15/13 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 1931710 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06802592.3 |
| Date of filing the European patent application | 2006-08-29 | |
| (97) | Date of publication of the European application | 2008-06-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-18 |
| (46) | Date of publication of the claims translation | 2017-03-27 |
| (86) | Number | PCT/US2006/033764 |
| Date | 2006-08-29 |
| (87) | Number | WO 2007/027714 |
| Date | 2007-03-08 |
| (30) | Number | Date | Country code |
| 713585 P | 2005-08-31 | US |
| (72) |
PRESTA, Leonard, G., US
ORTH, Peter, US
BEYER, Brian, M., US
LIU, Yan-Hui, US
INGRAM, Richard, N., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Rekombinantiniai anti-IL-23 antikūnai |
| ENGINEERED ANTI-IL-23 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2022-08-11 | 17 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-07-14 |